Drug class
Musculotropic gastrointestinal antispasmodic
Mechanism of action
Acts directly on gastrointestinal smooth muscle without materially affecting normal gut motility. The exact mechanism is not fully known; proposed contributing actions include altered ion-channel permeability, noradrenaline reuptake inhibition, local anaesthetic activity and weak antimuscarinic/phosphodiesterase effects.
General use cases
- Symptomatic treatment of irritable bowel syndrome
- Other functional bowel conditions associated with colicky abdominal pain, cramps, spastic constipation, diarrhoea and flatulence, according to product information
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
